目前、内科治疗冠心病的药物繁多,各种新型药物相继问世。过去,不少药物一开始就广泛应用,其疗效评价缺乏确实的临床验证。现在普遍认为随机分组、设立对照的临床试验是评价药物疗效最科学的方法,而观察治疗冠心病的药物疗效,则应以梗塞(再梗塞)、猝死的患病率和病死率为指标。本文就此予以综述。β-阻滞剂β-阻滞 Currently, medical treatment of coronary heart disease many drugs, all kinds of new drugs have come out. In the past, many drugs were widely used from the outset, and their efficacy evaluation lacks proven clinical validation. It is now generally accepted that randomized, controlled clinical trials are the most scientific method of evaluating drug efficacy. Observing the drug’s efficacy in treating coronary heart disease should be based on the prevalence of infarction (reinfarction), sudden death, and mortality. This article gives an overview of this. β-blocker β-block